|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/496 | |
| A61P 35/00 |
| (11) | Number of the document | 2558095 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11715691.9 |
| Date of filing the European patent application | 2011-04-14 | |
| (97) | Date of publication of the European application | 2013-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/055906 |
| Date | 2011-04-14 |
| (87) | Number | WO 2011/128403 |
| Date | 2011-10-20 |
| (30) | Number | Date | Country code |
| 324936 P | 2010-04-16 | US |
| (72) |
GRAUS-PORTA, Diana, CH
SCHMID, Herbert, CH
SHI, Michael, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | ORGANIC COMPOUND FOR USE IN THE TREATMENT OF LIVER CANCER |
| ORGANIC COMPOUND FOR USE IN THE TREATMENT OF LIVER CANCER |